PGNY
Progyny Inc
NASDAQ · Health Care
$21.95
+0.03 (+0.14%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 1.05B | 795.07M | 327.53M | 328.65M | 361.52M |
| Net Income | 49.08M | 33.31M | 43.08M | 34.13M | 42.27M |
| EPS | — | — | — | — | — |
| Profit Margin | 4.7% | 4.4% | 13.2% | 10.4% | 11.7% |
| Rev Growth | +32.6% | +32.6% | -4.1% | -2.1% | +18.2% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 400.73M | 534.59M | 401.19M |
| Total Equity | — | — | 1.03B | 927.29M | 982.54M |
| D/E Ratio | — | — | 0.39 | 0.58 | 0.41 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 63.80M | 45.71M | 72.21M | 62.54M | 73.50M |
| Free Cash Flow | — | — | 32.17M | 47.89M | 44.04M |